|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Paul A, Das S, Das J, et al:
Diarylheptanoid-myricanone isolated from ethanolic extract of
Myrica cerifera shows anticancer effects on HeLa and PC3 cell
lines: signalling pathway and drug-DNA interaction. J Integr Med.
11:405–415. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhai XF, Chen Z, Li B, et al: Traditional
herbal medicine in preventing recurrence after resection of small
hepatocellular carcinoma: a multicenter randomized controlled
trial. J Integr Med. 11:90–100. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhao L, Zhao AG, Zhao G, et al: Survival
benefit of traditional Chinese herbal medicine (a herbal formula
for invigorating spleen) in gastric cancer patients with peritoneal
metastasis. Evid Based Complement Alternat Med. 2014:6254932014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qian Y, Jin Y, Li Y and Ling C: Inhibitive
effect of 981208 agent on cell proliferating of
hepatocarcinogenesis induced by diethyl nitros-amine in rats. Acad
J Sec Mil Med Univ. 22:558–560. 2001.
|
|
6
|
Qian Y, Jin Y, Li Y, Li B and Ling C:
Experimental study of mechanism of Ganfujian granule inhibiting
hepatocarcinogenesis induced with Diethylnitrosamine in rats. J
Zhejiang Chin Med Univ. 27:56–58. 2003.
|
|
7
|
Mao ZJ, Tang QJ, Zhang CA, et al:
Anti-proliferation and anti-invasion effects of diosgenin on
gastric cancer BGC-823 cells with HIF-1α shRNA s. Int J Mol Sci.
13:6521–6533. 2012. View Article : Google Scholar
|
|
8
|
He Z, Tian Y, Zhang X, et al: Anti-tumour
and immuno-modulating activities of diosgenin, a naturally
occurring steroidal saponin. Nat Prod Res. 26:2243–2246. 2012.
View Article : Google Scholar
|
|
9
|
Liu MJ, Wang Z, Ju Y, Wong RN and Wu QY:
Diosgenin induces cell cycle arrest and apoptosis in human leukemia
K562 cells with the disruption of Ca2+ homeostasis.
Cancer Chemother Pharmacol. 55:79–90. 2005. View Article : Google Scholar
|
|
10
|
Lepage C, Leger DY, Bertrand J, Martin F,
Beneytout JL and Liagre B: Diosgenin induces death receptor-5
through activation of p38 pathway and promotes TRAIL-induced
apoptosis in colon cancer cells. Cancer Lett. 301:193–202. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He Z, Chen H, Li G, et al: Diosgenin
inhibits the migration of human breast cancer MDA-MB-231 cells by
suppressing Vav2 activity. Phytomedicine. 21:871–876. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Du J, Cheng B, Zhu X and Ling C:
Ginsenoside Rg1, a novel glucocorticoid receptor agonist of plant
origin, maintains glucocorticoid efficacy with reduced side
effects. J Immunol. 187:942–950. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Binbin C, Yinglu F, Juan D and Changquan
L: Upregulation effect of ginsenosides on glucocorticoid receptor
in rat liver. Horm Metab Res. 41:531–536. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li F, Fernandez PP, Rajendran P, Hui KM
and Sethi G: Diosgenin, a steroidal saponin, inhibits STAT3
signaling pathway leading to suppression of proliferation and
chemosensitization of human hepatocellular carcinoma cells. Cancer
Lett. 292:197–207. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Moalic S, Liagre B, Corbiere C, et al: A
plant steroid, diosgenin, induces apoptosis, cell cycle arrest and
COX activity in osteosarcoma cells. FEBS Lett. 506:225–230. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Leger DY, Liagre B, Corbiere C,
Cook-Moreau J and Beneytout JL: Diosgenin induces cell cycle arrest
and apoptosis in HEL cells with increase in intracellular calcium
level, activation of cPLA2 and COX-2 overexpression. Int J Oncol.
25:555–562. 2004.PubMed/NCBI
|
|
17
|
Satyanarayana A, Hilton MB and Kaldis P:
p21 inhibits Cdk1 in the absence of Cdk2 to maintain the G1/S phase
DNA damage checkpoint. Mol Biol Cell. 19:65–77. 2008. View Article : Google Scholar :
|
|
18
|
Chan TA, Hwang PM, Hermeking H, Kinzler KW
and Vogelstein B: Cooperative effects of genes controlling the
G(2)/M checkpoint. Genes Dev. 14:1584–1588. 2000.PubMed/NCBI
|
|
19
|
Lee E, Kwak GH, Kamble K and Kim HY:
Methionine sulfoxide reductase B3 deficiency inhibits cell growth
through the activation of p53-p21 and p27 pathways. Arch Biochem
Biophys. 547:1–5. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Masgras I, Carrera S, de Verdier PJ, et
al: Reactive oxygen species and mitochondrial sensitivity to
oxidative stress determine induction of cancer cell death by p21. J
Biol Chem. 287:9845–9854. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yadav V, Sultana S, Yadav J and Saini N:
Gatifloxacin induces S and G2-phase cell cycle arrest in pancreatic
cancer cells via p21/p27/p53. PLoS One. 7:e477962012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pal I and Mandal M: PI3K and Akt as
molecular targets for cancer therapy: current clinical outcomes.
Acta Pharmacol Sin. 33:1441–1458. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liang J and Slingerland JM: Multiple roles
of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell
Cycle. 2:339–345. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Osaki M, Oshimura M and Ito H: PI3K-Akt
pathway: its functions and alterations in human cancer. Apoptosis.
9:667–676. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Izutani Y, Yogosawa S, Sowa Y and Sakai T:
Brassinin induces G1 phase arrest through increase of p21 and p27
by inhibition of the phosphatidylinositol 3-kinase signaling
pathway in human colon cancer cells. Int J Oncol. 40:816–824.
2012.PubMed/NCBI
|
|
26
|
Georgakis GV, Li Y, Rassidakis GZ,
Medeiros LJ, Mills GB and Younes A: Inhibition of the
phosphatidylinositol-3 kinase/Akt promotes G1 cell cycle arrest and
apoptosis in Hodgkin lymphoma. Br J Haematol. 132:503–511.
2006.PubMed/NCBI
|
|
27
|
Leger DY, Liagre B and Beneytout JL: Role
of MAPKs and NF-κB in diosgenin-induced megakaryocytic
differentiation and subsequent apoptosis in HEL cells. Int J Oncol.
28:201–207. 2006.
|
|
28
|
Shishodia S and Aggarwal BB: Diosgenin
inhibits osteoclastogenesis, invasion, and proliferation through
the downregulation of Akt, I kappa B kinase activation and NF-kappa
B-regulated gene expression. Oncogene. 25:1463–1473. 2006.
View Article : Google Scholar
|
|
29
|
Srinivasan S, Koduru S, Kumar R,
Venguswamy G, Kyprianou N and Damodaran C: Diosgenin targets
Akt-mediated prosurvival signaling in human breast cancer cells.
Int J Cancer. 125:961–967. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zinkel S, Gross A and Yang E: BCL2 family
in DNA damage and cell cycle control. Cell Death Differ.
13:1351–1359. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim DS, Jeon BK, Lee YE, Woo WH and Mun
YJ: Diosgenin induces apoptosis in HepG2 cells through generation
of reactive oxygen species and mitochondrial pathway. Evid Based
Complement Alternat Med. 2012:9816752012. View Article : Google Scholar : PubMed/NCBI
|
